(1)
Clinical Experience of the Use of Vasavital® in Dry Age-Related Macular Degeneration and Ischemic Optic Neuropathy. Ukr. j. ophthalmol. 2025, No. 1, 38-45. https://doi.org/10.31288/oftalmolzh202113845.